as on January 16, 2026 at 4:01 pm IST
52 Week's Low
52 Week's High
21.63%
Downside
95.35%
Upside
as on January 16, 2026 at 4:01 pm IST
Market Cap
₹15.29 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.97
P/B Ratio
0.82
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
0EPS (TTM)
-21.06
Sector
Healthcare
Book Value
16.51
Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Vanta Bioscience with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 15.29 | -16.72% | 0.93 | -14 | 1 | |
| BUY | 1,155.96 | -14.69% | 0.69 | 29 | 392 | |
| NA | 722.19 | 14.08% | 0.66 | 23 | 230 | |
| BUY | 8,955.01 | 5.39% | 0.61 | 193 | 1,261 | |
| NA | 66.81 | 2.66% | 0.62 | 4 | 28 |
Get share price movements and forecasts by analysts on Vanta Bioscience.
Source: S&P Global Market Intelligence
Search interest for Vanta Bioscience Ltd Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:11% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vanta Bioscience.
Vanta Bioscience Ltd’s net profit fell -2042.86% since last year same period to ₹-1.36Cr in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated 46.88% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Take Solutions Ltd has given 177.2% return, outperforming this stock by 223.4%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 27.19% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 165.6% return, outperforming this stock by 230.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 72.81% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 3 years, Vanta Bioscience stock has moved down by -64.4%
| Organisation | Vanta Bioscience Ltd |
| Industry | Healthcare |
| CEO | Mohan Krishna Mulakala |
| E-voting on shares | Click here to vote |
Vanta Bioscience share price today stands at ₹21.5 as on at the close of the market. Vanta Bioscience share today touched a day high of ₹21.5 and a low of ₹21.5.
Vanta Bioscience touched a 52 week high of ₹42 and a 52 week low of ₹16.85. Vanta Bioscience share price today i.e. is closed at ₹21.5, which is -48.81% down from its 52 week high and 27.60% up from its 52 week low.
Vanta Bioscience market capitalisation is ₹15.29 Cr as on .
To buy Vanta Bioscience shares, you need to follow these steps:
Vanta Bioscience trading volume is 4,500.00 as on . This means that 4,500.00 shares of Vanta Bioscience were bought and sold on the stock market during today's trading session.